Aurora Cannabis (FRA:21P) Cyclically Adjusted Revenue per Share: €9.40 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:21P Aurora Cannabis Inc FRA:21P
58 GF Score
Price €2.33
GF Value €3.56
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis Cyclically Adjusted Revenue per Share?

Aurora Cannabis FRA:21P +0.95% 58 Cyclically Adjusted Revenue per Share is €9.40 as of Mar. 2026. GuruFocus rates FRA:21P with a GF Score™ of 58/100 and a GF Value™ of €3.56 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Aurora Cannabis's adjusted revenue per share for the three months ended in Mar. 2026 was €0.417. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €9.40 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Aurora Cannabis's average Cyclically Adjusted Revenue Growth Rate was -1.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -5.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Aurora Cannabis was 49.80% per year. The lowest was -5.70% per year. And the median was 1.40% per year.

As of today (2026-07-26), Aurora Cannabis's current stock price is €2.326. Aurora Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €9.40. Aurora Cannabis's Cyclically Adjusted PS Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aurora Cannabis was 230.43. The lowest was 0.24. And the median was 3.81.


Aurora Cannabis  (FRA:21P) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aurora Cannabis's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.326/9.40
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aurora Cannabis was 230.43. The lowest was 0.24. And the median was 3.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Aurora Cannabis Cyclically Adjusted Revenue per Share Related Terms


Aurora Cannabis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Aurora Cannabis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Cannabis Cyclically Adjusted Revenue per Share Chart

Aurora Cannabis Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.53 13.94 11.54 10.19 9.40

Aurora Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.19 9.78 9.02 9.79 9.40

FRA:21P vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's Cyclically Adjusted PS Ratio falls into.


FRA:21P
58GF Score
Aurora Cannabis Inc FRA:21P
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Cannabis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aurora Cannabis's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.417/132.2623*132.2623
=0.417

Current CPI (Mar. 2026) = 132.2623.

Aurora Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.746 102.002 0.967
201609 1.364 101.765 1.773
201612 1.255 101.449 1.636
201703 1.385 102.634 1.785
201706 1.337 103.029 1.716
201709 1.798 103.345 2.301
201712 2.358 103.345 3.018
201803 2.530 105.004 3.187
201806 2.482 105.557 3.110
201809 2.713 105.636 3.397
201812 4.389 105.399 5.508
201903 5.156 106.979 6.375
201906 7.605 107.690 9.340
201909 5.835 107.611 7.172
201912 4.154 107.769 5.098
202003 4.774 107.927 5.850
202006 3.901 108.401 4.760
202009 3.693 108.164 4.516
202012 2.585 108.559 3.149
202103 1.901 110.298 2.280
202106 1.882 111.720 2.228
202109 2.036 112.905 2.385
202112 2.113 113.774 2.456
202203 1.685 117.646 1.894
202206 1.490 120.806 1.631
202209 1.242 120.648 1.362
202212 1.313 120.964 1.436
202303 1.327 122.702 1.430
202306 1.468 124.203 1.563
202309 1.098 125.230 1.160
202312 0.928 125.072 0.981
202403 0.886 126.258 0.928
202406 1.089 127.522 1.129
202409 0.958 127.285 0.995
202412 1.060 127.364 1.101
202503 0.422 129.181 0.432
202506 1.106 129.892 1.126
202509 0.974 130.287 0.989
202512 1.017 130.366 1.032
202603 0.417 132.262 0.417

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €9.40 mean?
Aurora Cannabis (FRA:21P) has a Cyclically Adjusted Revenue per Share of €9.40 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aurora Cannabis and its competitors.
Is Aurora Cannabis' Cyclically Adjusted Revenue per Share too high?
Aurora Cannabis' current Cyclically Adjusted Revenue per Share is €9.40. Overall, Aurora Cannabis has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Aurora Cannabis' Cyclically Adjusted Revenue per Share of €9.40 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aurora Cannabis and its competitors. Aurora Cannabis's current Cyclically Adjusted Revenue per Share is €9.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (FRA:21P) is currently considered Possible Value Trap. The stock's GF Value™ is €3.56, compared to a current price of €2.33 — trading 34.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €9.40. Aurora Cannabis' overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Aurora Cannabis (FRA:21P), the current Cyclically Adjusted Revenue per Share is €9.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Cannabis (FRA:21P) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of €2.33 is trading 34.7% below its estimated GF Value™ of €3.56. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for FRA:21P:

  • Cyclically Adjusted Revenue per Share: €9.40
  • GF Value™: €3.56 vs. price of €2.33 (34.7% below fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the FRA:21P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
58GF Score

Get the complete analysis for FRA:21P

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.33
Price
€3.56
GF Value